Gritstone bio, Inc. / Fundamentals
Income statement
- Net revenue
€1.46M - Cost of goods sold
€6.23M - Gross profit
-€4.76M - SG&A expenses
€22.62M - R&D expenses
€103.00M - EBITDA
-€104.24M - D&A
€6.23M - EBIT
-€128.69M - Interest expenses
€4.14M - EBT
-€114.61M - Tax expenses
€625.25K - Net income
-€114.61M
Cash flow statement
- Net deferred tax
€691.82K - Non-cash items
€22.08M - Changes in working capital
-€22.07M - Operating cash flow
-€108.42M - Capex
€1.26M - Other investing cash flow
-€32.27M - Net investing cash flow
€58.58M - Total cash dividends paid
-€639.27K - Issuance of common stock
€37.63M - Debt repayment
€8.37M - Other financing cash flow
-€1.63M - Net financing cash flow
€56.50M - Foreign exchange effects
€0.00 - Net change in cash
€7.17M - Cash at end of period
€44.95M - Free cash flow
-€107.16M
Balance sheet
- Cash and cash equivalents
€44.95M - Cash and short-term investments
€49.10M - Total receivables
€168.00K - Inventory
€0.00 - Other current assets
€4.14M - Total current assets
€52.30M - Property, plant & equipment
€65.93M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€4.04M - Other non-current assets
€524.68K - Total non-current assets
€70.50M - Total assets
€122.81M - Accounts payable
€3.56M - Short-term debt
€12.34M - Other current liabilities
€4.09M - Total current liabilities
€20.59M - Long-term debt
€82.14M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€962.35K - Total non-current liabilities
€83.10M - Total liabilities
€103.69M - Common stock
€20.68K - Retained earnings
-€623.19M - Other equity
-€2.58K - Total equity
€19.12M - Total liabilities and shareholders' equity
€122.81M
Company information
- Market capitalization
€3.24M - Employees
231 - Enterprise Value
€54.12M
Company ratios
- Gross margin
-
-325.1% Much worse than peer group: -69.0% - EBITDA margin
-
-7,117.5% Much worse than peer group: -1,241.4% - EBIT margin
-
-8,786.8% Much worse than peer group: -1,070.5% - EBT margin
-
-7,825.5% Much worse than peer group: -1,432.2% - Net margin
-
-7,825.5% Much worse than peer group: -1,411.4% - ROE
-
-599.5% Much worse than peer group: 113.9% - ROA
-
-93.3% Much worse than peer group: -52.5% - Asset turnover
-
1.2% Worse than peer group: 14.2% - FCF margin
-
-7,488.2% Much worse than peer group: -888.0% - FCF yield
-3,381.0% - Efficiency ratio
7,217.5% - Net sales per employee
-
€6.34K - Net income per employee
-
-€496.17K